Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024<br/><br/>Offer reference number: CM/PHS/24/5709<br/><br/>Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority’s discretion) for a further period (or periods) up to a total of 24 months
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Abbvie Ltd | 08004972 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
| Amarox Limited | 10997632 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| Dr.Reddy's Laboratories (UK) Limited | 01729064 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| Gilead Sciences Ltd | 02543818 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter) |
| JANSSEN-CILAG LIMITED | 01027904 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Ovid Consulting Ltd (4 quarters) |
| Lupin Healthcare (UK) Limited | 06925119 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| Macleods Pharma UK Limited | 06455382 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| Mawdsley-Brooks and Co Ltd | - | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| MERCK SHARP and DOHME (UK) LIMITED | - | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| Milpharm Ltd/aurobinbdo | - | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| MSN Laboratories Europe Limited | 10185013 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
| Mylan UK Healthcare Limited | 09189103 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | LOBBYIST Instinctif Partners Holdings Limited (1 quarter) |
| ViiV Healthcare UK Ltd | 06990358 | ~£1,080,000,000 estimated from lot values | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 273 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Nov 2024 – Oct 2026 | £1,080,000,000 £13 initial term | 21 | Gilead Sciences Ltd ViiV Healthcare UK Ltd Milpharm Ltd/aurobinbdo MERCK SHARP and DOHME (UK) LIMITED Mawdsley-Brooks and Co Ltd Abbvie Ltd JANSSEN-CILAG LIMITED Lupin Healthcare (UK) Limited Dr.Reddy's Laboratories (UK) Limited Macleods Pharma UK Limited Mylan UK Healthcare Limited MSN Laboratories Europe Limited Amarox Limited | active |
Weightings from the notice.
Government spending data: These suppliers have received £240,593,240 in 2,498 payments (over £25k) from Department of Health and Social Care, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT and 16 more public bodies (2017-09-30 to 2026-03-31).
Changes the buyer published to this notice after it first appeared.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.